Search research articles
Contact Us
Filters
Showing results (111-120 of 141) with videos related to
Page
of 15
Sort By:
European Journal of Heart Failure
|
March 3, 2020
Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure
Pooja Dewan, Alice Jackson, Carolyn S P Lam, et al.
European Journal of Heart Failure
|
September 18, 2021
Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES
Su E Yeoh, Pooja Dewan, Matteo Serenelli, et al.
JACC. Heart Failure
|
January 14, 2020
Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction
Matteo Serenelli, Alice Jackson, Pooja Dewan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 28, 2020
Covariate adjusted reanalysis of the I-Preserve trial
João Pedro Ferreira, Pooja Dewan, Pardeep S Jhund, et al.
Global Heart
|
February 26, 2024
Peer Support for Type 2 Diabetes Management in Low- and Middle-Income Countries (LMICs): A Scoping Review
Diana Sherifali, Lilian Pinto da Silva, Pooja Dewan, et al.
ESC Heart Failure
|
October 20, 2020
Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HF
Su E Yeoh, Pooja Dewan, Akshay S Desai, et al.
Circulation. Heart Failure
|
March 21, 2023
Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial
Jawad H Butt, Wasyla Ibrahim, Pooja Dewan, et al.
Circulation. Heart Failure
|
November 9, 2020
Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy?
Su E Yeoh, Pooja Dewan, Pardeep S Jhund, et al.
Circulation
|
June 27, 2023
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
Toru Kondo, Pooja Dewan, Inder S Anand, et al.
Circulation. Heart Failure
|
March 3, 2025
Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
Mingming Yang, Toru Kondo, Pooja Dewan, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 141) with videos related to
Sort By:
Page
of 15
European Journal of Heart Failure
|
March 3, 2020
Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure
Pooja Dewan, Alice Jackson, Carolyn S P Lam, et al.
European Journal of Heart Failure
|
September 18, 2021
Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES
Su E Yeoh, Pooja Dewan, Matteo Serenelli, et al.
JACC. Heart Failure
|
January 14, 2020
Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction
Matteo Serenelli, Alice Jackson, Pooja Dewan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 28, 2020
Covariate adjusted reanalysis of the I-Preserve trial
João Pedro Ferreira, Pooja Dewan, Pardeep S Jhund, et al.
Global Heart
|
February 26, 2024
Peer Support for Type 2 Diabetes Management in Low- and Middle-Income Countries (LMICs): A Scoping Review
Diana Sherifali, Lilian Pinto da Silva, Pooja Dewan, et al.
ESC Heart Failure
|
October 20, 2020
Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HF
Su E Yeoh, Pooja Dewan, Akshay S Desai, et al.
Circulation. Heart Failure
|
March 21, 2023
Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial
Jawad H Butt, Wasyla Ibrahim, Pooja Dewan, et al.
Circulation. Heart Failure
|
November 9, 2020
Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy?
Su E Yeoh, Pooja Dewan, Pardeep S Jhund, et al.
Circulation
|
June 27, 2023
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
Toru Kondo, Pooja Dewan, Inder S Anand, et al.
Circulation. Heart Failure
|
March 3, 2025
Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
Mingming Yang, Toru Kondo, Pooja Dewan, et al.
Page
of 15